Business
Energy giants told to pass on £150 discount to customers
The Government has instructed energy companies to ensure that customers on fixed tariffs also benefit from the £150 reduction in household bills, a measure announced in the recent Budget.
Chancellor Rachel Reeves confirmed her intention to lower energy costs and alleviate the cost of living, with an average household bill set to decrease by £150 from April.
This saving, Ms Reeves explained, would be achieved by abolishing the Energy Company Obligation (Eco) scheme, which she asserted had burdened households with an additional £1.7 billion annually.
Energy Secretary Ed Miliband formally wrote to energy firms on Wednesday, urging them to extend the benefit of this reduction to consumers currently on fixed energy tariffs.
These tariffs guarantee a consistent unit rate and standing charge for the duration of the agreed contract, typically a year or longer.
In contrast, those on standard variable tariffs experience fluctuating rates, which adjust according to wholesale market costs paid by suppliers, without a set timeframe.
In his letter, Mr Miliband wrote: “This Government has made a clear commitment to cut people’s bills and help ease the financial pressure on millions of families, as we know energy costs cause such anxiety for many people, and that is why we are acting now.
“As we move forward, we want to set out our clear expectation that every single penny of our intervention at this Budget is passed on to consumers, including those on existing fixed term tariffs.
“Around 37% of the market is now on a fixed term tariff and Government is clear that they must benefit from this reduction in bills.
“We urge you to continue to work with our department to ensure that this happens.
“This close, joint working will be both welcomed and reassuring for customers, demonstrating our shared commitment to fairness and consumer protection.
“Thank you once again for your partnership and for your efforts to ensure that these positive changes reach every household.”
According to latest Ofgem figures, around 21 million domestic customers’ energy accounts are on fixed tariffs, while around 34 million remain on standard variable tariffs.
Ned Hammond, deputy director of customer policy at Energy UK, which represents suppliers, said: “The energy industry has long called for Government action to reduce costs, having seen directly how many households are struggling to afford their energy bills and with customer debt at record levels.
“So last week’s Budget announcement was very welcome and suppliers will of course look to pass on the savings. However, it’s also expected that there will be some new costs added to bills over the coming months.
“While most customers remain on the price cap, where the amount they pay for energy is set by Ofgem, suppliers also set their own fixed tariffs to compete on price with each other and so have every reason to pass on any cost savings with these.”
Business
Anthropic officially designated a supply chain risk by Pentagon
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Business1 week agoHouseholds set for lower energy bills amid price cap shake-up
-
Fashion7 days agoTexwin Spinning showcasing premium cotton yarn range at VIATT 2026
-
Business6 days agoGreggs to reveal trading amid pressure from cost of living and weight loss drugs
